Bio-key International Share Price (NASDAQ: BKYI)

$0.75

Last updated on August 30, 2025 at 1:26 am IST

$₹

Check the interactive Bio-key International Stock chart to analyse performance

Bio-key International stock performance

as on August 30, 2025 at 1:26 am IST

Today's Low:$0.74
Today's High:$0.76
$0.75
1.13%
Downside
Day's Volatility :1.79%
Upside
0.66%
52 Weeks Low:$0.52
52 Weeks High:$3.68
$0.75
30.84%
Downside
52 Weeks Volatility :85.9%
Upside
79.62%

Bio-key International Stock Returns

Period	Bio-key International Inc	Index (Russel 2000)
3 Months	-7.17%	0.0%
6 Months	-25.98%	0.0%
1 Year	-38.62%	0.0%
3 Years	-97.52%	-4.7%

Bio-key International Inc Key Stats

Check Bio-key International key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$0.75
Open	$0.75
Today's High	$0.755
Today's Low	$0.7415
Market Capitalization	$5.2M
Today's Volume	$57.0K
52 Week High	$3.68
52 Week Low	$0.5187
Revenue TTM	$6.9M
EBITDA	$-3.2M
Earnings Per Share (EPS)	$-1.12
Profit Margin	-58.27%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-138.97%

Stock Returns calculator for Bio-key International Stock including INR - Dollar returns

The Bio-key International stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Bio-key International investment value today

Current value as on today

₹61,675

Returns

₹38,325

(-38.32%)

Returns from Bio-key International Stock

₹43,609 (-43.61%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Bio-key International Stock

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Bio-key International Stock from India on INDmoney has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Bio-key International Inc

Name
Holdings %
Name
Holdings %
TWO SIGMA SECURITIES, LLC
0.37%
Geode Capital Management, LLC
0.32%
Virtu Financial LLC
0.22%
Tower Research Capital LLC
0.03%

Analyst Recommendation on Bio-key International Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Bio-key International(by analysts ranked 0 to 5 stars)

Bio-key International Share Price Target

What analysts predicted

Upside of 166.67%

Target:

$2.00

Current:

$0.75

Bio-key International share price target is $2.00, a slight Upside of 166.67% compared to current price of $0.75 as per analysts' prediction.

Bio-key International Stock Insights

Price Movement
In the last 3 years, BKYI stock has moved down by -97.5%
Increasing Revenue
Revenue is up for the last 3 quarters, 1.46M → 1.69M (in $), with an average increase of 7.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -736.54K → -1.16M (in $), with an average decrease of 58.5% per quarter
BKYI vs ALLE (1 yr)
In the last 1 year, Allegion Plc has given 22.3% return, outperforming this stock by 65.5%
BKYI vs BCO (3 yr)
In the last 3 years, The Brink's Company has given 75.7% return, outperforming this stock by 173.2%
Price to Sales
ForBKYI every $1 of sales, investors are willing to pay $0.4, whereas for Allegion Plc, the investors are paying $3.8 for every $1 of sales.

Bio-key International Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$2.3M	↓ 43.94%
Net Income	$-14.7M	↑ 113.32%
Net Profit Margin	-646.21%	↓ 476.38%

	FY20	Y/Y Change
Revenue	$2.8M	↑ 25.1%
Net Income	$-9.7M	↓ 33.98%
Net Profit Margin	-341.02%	↑ 305.19%

	FY21	Y/Y Change
Revenue	$5.1M	↑ 80.29%
Net Income	$-5.1M	↓ 47.64%
Net Profit Margin	-99.05%	↑ 241.97%

	FY22	Y/Y Change
Revenue	$7.0M	↑ 37.26%
Net Income	$-11.9M	↑ 135.1%
Net Profit Margin	-169.65%	↓ 70.6%

	FY23	Y/Y Change
Revenue	$7.8M	↑ 10.46%
Net Income	$-8.5M	↓ 28.45%
Net Profit Margin	-109.89%	↑ 59.76%

	FY24	Y/Y Change
Revenue	$6.9M	↓ 10.64%
Net Income	$-4.3M	↓ 49.53%
Net Profit Margin	-62.06%	↑ 47.83%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$2.2M	↓ 3.92%
Net Income	$-510.3K	↓ 87.55%
Net Profit Margin	-23.39%	↑ 157.21%

	Q2 FY24	Q/Q Change
Revenue	$1.1M	↓ 47.68%
Net Income	$-1.7M	↑ 226.67%
Net Profit Margin	-146.06%	↓ 122.67%

	Q3 FY24	Q/Q Change
Revenue	$2.1M	↑ 87.93%
Net Income	$-739.0K	↓ 55.67%
Net Profit Margin	-34.45%	↑ 111.61%

	Q4 FY24	Q/Q Change
Revenue	$1.5M	↓ 31.82%
Net Income	$-1.4M	↑ 87.36%
Net Profit Margin	-94.68%	↓ 60.23%

	Q1 FY25	Q/Q Change
Revenue	$1.6M	↑ 9.91%
Net Income	$-736.5K	↓ 46.8%
Net Profit Margin	-45.83%	↑ 48.85%

	Q2 FY25	Q/Q Change
Revenue	$1.7M	↑ 5.58%
Net Income	$-1.2M	↑ 58.5%
Net Profit Margin	-68.8%	↓ 22.97%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$-193.7K	↑ 61.91%

	FY20	Y/Y Change
Profit	$2.0M	↓ 1154.09%

	FY21	Y/Y Change
Profit	$3.4M	↑ 68.54%

	FY22	Y/Y Change
Profit	$4.6M	↑ 33.1%

	FY23	Y/Y Change
Profit	$1.4M	↓ 68.75%

	FY24	Y/Y Change
Profit	$5.6M	↑ 294.06%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$1.9M	↓ 17.12%

	Q2 FY24	Q/Q Change
Profit	$879.0K	↓ 53.28%

	Q3 FY24	Q/Q Change
Profit	$1.7M	↑ 91.09%

	Q4 FY24	Q/Q Change
Profit	$1.2M	↓ 28.56%

	Q1 FY25	Q/Q Change
Profit	$1.3M	↑ 10.65%

	Q2 FY25	Q/Q Change
Profit	$1.2M	↓ 7.15%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-1.9M	↑ 14.68%
Investing Cash Flow	$-543.3K	↑ 558.89%
Financing Cash Flow	$2.1M	↑ 24.12%

	FY20	Y/Y Change
Operating Cash Flow	$-5.0M	↑ 167.52%
Investing Cash Flow	$-2.2M	↑ 310.41%
Financing Cash Flow	$24.1M	↑ 1021.32%

	FY21	Y/Y Change
Operating Cash Flow	$-9.0M	↑ 81.38%
Investing Cash Flow	$-42.0K	↓ 98.12%
Financing Cash Flow	$-218.6K	↓ 100.91%

	FY22	Y/Y Change
Operating Cash Flow	$-6.2M	↓ 30.62%
Investing Cash Flow	$-696.6K	↑ 1557.67%
Financing Cash Flow	$1.9M	↓ 970.66%

	FY23	Y/Y Change
Operating Cash Flow	$-3.8M	↓ 39.1%
Investing Cash Flow	$-1000.0	↓ 99.86%
Financing Cash Flow	$1.4M	↓ 24.68%

	FY24	Y/Y Change
Operating Cash Flow	$-2.9M	↓ 23.18%
Investing Cash Flow	$-13.0K	↑ 1204.7%
Financing Cash Flow	$2.8M	↑ 97.21%

Q1 FY24

Q3 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$297.1K	↓ 119.4%
Investing Cash Flow	$-1.9K	-
Financing Cash Flow	$-53.9K	↓ 103.46%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-1.3M	↓ 10.18%
Investing Cash Flow	$-21.2K	-
Financing Cash Flow	$1.7M	↓ 11.1%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-835.3K	↑ 62.33%
Investing Cash Flow	$-4.6K	-
Financing Cash Flow	$3.5M	↓ 523.39%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-880.0K	↑ 5.35%
Investing Cash Flow	$-1.5K	↓ 67.66%
Financing Cash Flow	$-35.7K	↓ 101.01%

Bio-key International Technicals Summary

Sell

Neutral

Buy

Bio-key International is currently in a neutral trading position according to technical analysis indicators.

Bio-key International Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bio-key International Inc	-0.53%	-25.98%	-38.62%	-97.52%	-99.05%
Msa Safety Inc	-2.88%	6.34%	-3.23%	44.72%	33.81%
Allegion Plc	2.85%	34.24%	23.97%	77.42%	66.35%
Brady Corp	11.09%	10.79%	5.9%	68.6%	65.73%
Adt Corp., The	4.94%	13.26%	21.99%	20.3%	-21.53%
The Brink's Company	31.52%	26.58%	4.92%	101.84%	146.73%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bio-key International Inc	NA	NA	0.0	-0.5	-1.39	-0.29	NA	1.0
Msa Safety Inc	24.69	24.69	1.7	7.9	0.24	0.11	0.01	31.91
Allegion Plc	23.75	23.75	2.09	8.12	0.39	0.11	0.01	20.81
Brady Corp	19.16	19.16	2.5	4.58	0.18	0.1	0.01	24.68
Adt Corp., The	12.23	12.23	NA	0.87	0.17	0.05	0.03	4.43
The Brink's Company	30.2	30.2	2.83	7.95	0.42	0.04	0.01	6.09

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bio-key International Inc	Buy	$5.2M	-99.05%	NA	-58.27%
Msa Safety Inc	Buy	$6.8B	33.81%	24.69	15.15%
Allegion Plc	Buy	$14.7B	66.35%	23.75	16.15%
Brady Corp	Buy	$3.7B	65.73%	19.16	13.35%
Adt Corp., The	Buy	$7.1B	-21.53%	12.23	12.31%
The Brink's Company	Buy	$4.7B	146.73%	30.2	3.21%

About Bio-key International Inc

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education sectors in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, services, and cloud host, as well as windows device authentication through IAM platform. The company's solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and civil and large-scale ID infrastructure solutions that develop finger-based biometric technology. Further, the company offers finger scanners for enterprise and consumer markets under SideSwipe, PIV Pro, EcoID II, and SidePass brand names; and fingerprint readers. Additionally, it provides identity and access management, user multi-factor authentication, and privilege entitlement and access control solutions. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.

Organization	Bio-key International
Employees	41
CEO	Mr. Michael W. DePasquale
Industry	Technology Services

Key Management of Bio-key International Inc

Name	Title
Mr. Michael W. DePasquale	Chairman & CEO
Ms. Cecilia C. Welch	Chief Financial Officer
Mr. James David Sullivan	Senior VP of Strategy & Compliance and Chief Legal Officer
Ms. Mira K. LaCous	Chief Technology Officer
Mr. Akintunde Carlton Jeje	Managing Director of Africa
Mr. Alex Rocha	Managing Director of EMEA
Mr. Mark Cochran	President of PortalGuard

Important FAQs about investing in BKYI Stock from India :

What is Bio-key International share price today?

Bio-key International share price today is $0.75 as on August 30, 2025 at 1:26 am IST at the close of the market. Bio-key International share today touched a day high of $0.76 and a low of $0.74.

What is the 52 week high and 52 week low for Bio-key International share?

Bio-key International share touched a 52 week high of $3.68 and a 52 week low of $0.52. Bio-key International stock price today i.e. August 30, 2025 at 1:26 am IST is closed at $0.75, lower by 79.62% versus the 52 week high.

How to invest in Bio-key International Stock (BKYI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Bio-key International on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bio-key International Shares that will get you 2.0000 shares as per Bio-key International share price of $0.75 per share as on August 30, 2025 at 1:26 am IST.

What is the minimum amount required to buy Bio-key International Stock (BKYI) from India?

Indian investors can start investing in Bio-key International (BKYI) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Bio-key International stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Bio-key International share’s latest price of $0.75 as on August 30, 2025 at 1:26 am IST, you will get 13.3333 shares of Bio-key International. Learn more about fractional shares .

What are the returns that Bio-key International has given to Indian investors in the last 5 years?

Bio-key International stock has given -99.05% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?